Menest and Profen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Menest (estrogens, esterified) and Profen (ibuprofen). Common drug interactions include visual acuity reduced among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Menest and Profen. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Menest?

Menest has active ingredients of estrogens, esterified. It is often used in hormone replacement therapy. eHealthMe is studying from 843 Menest users. Check the latest studies of Menest.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.



On Jul, 20, 2026

20 people who take Menest and Profen together, and have interactions are studied.

Menest and Profen drug interactions.

What are the common drug interactions of Menest and Profen, by gender? *:

female:

  1. Visual acuity reduced (reduced clearness of vision)
  2. Cystitis (inflammation of the wall of the bladder)
  3. Dyspnoea (difficult or laboured respiration)
  4. Aphagia (inability or refusal to swallow)
  5. Erythema (redness of the skin)
  6. Local swelling (swelling at the site of some application of substance or injury)
  7. Mouth injury
  8. Oral disorder (mouth disease)
  9. Periorbital disorder (gum inflammation to serious disease that results in major damage to the soft tissue and bone that support the teeth)
  10. Pharyngeal erythema (pharyngeal redness)

male:

  1. Anxiety
  2. Cardiac disorder
  3. Multiple fractures
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Osteoporosis (bones weak and more likely to break)
  7. Pelvic fracture
  8. Pneumonia
  9. Pyrexia (fever)
  10. Rib fracture

What are the common drug interactions of Menest and Profen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Aphagia (inability or refusal to swallow)
  2. Dyspnoea (difficult or laboured respiration)
  3. Erythema (redness of the skin)
  4. Local swelling (swelling at the site of some application of substance or injury)
  5. Mouth injury
  6. Oral disorder (mouth disease)
  7. Periorbital disorder (gum inflammation to serious disease that results in major damage to the soft tissue and bone that support the teeth)
  8. Pharyngeal erythema (pharyngeal redness)
  9. Speech disorder
  10. Stomatitis (inflammation of mucous membrane of mouth)

40-49:

  1. Anxiety
  2. Cardiac disorder
  3. Cerebral haemorrhage (bleeding within the brain)
  4. Compression fracture (fracture due to pressure caused by injury)
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Depression
  7. Emotional distress
  8. Foot fracture
  9. Gallbladder disorder
  10. Hip fracture

50-59:

  1. Arthralgia (joint pain)
  2. Chest pain
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Asthenia (weakness)
  6. Atrioventricular block complete (heart block complete)
  7. Bladder prolapse (bulging of one or more of the pelvic organs into the vagina)
  8. Bradycardia (abnormally slow heart action)
  9. Chronic kidney disease
  10. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)

60+:

  1. Arteriosclerosis (thickening and hardening of arteries)
  2. Bone density decreased
  3. Chronic kidney disease
  4. Low density lipoprotein increased (cholesterol increased in blood)
  5. Nipple disorder (disease of nipple)
  6. Seborrhoeic keratosis (noncancerous (benign) skin growths that some people develop as they age. they often appear on the back or chest)
  7. Spinal osteoarthritis (joint cartilage loss in spine)
  8. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  9. Fibrocystic breast disease (a condition causing breast pain, cysts, and noncancerous breast lumps, affects many women)
  10. Breast cancer female

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 4 people, 20.00%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 15.00%
  3. Sinus Disorder (disease of sinus): 2 people, 10.00%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 10.00%
  5. Back Disorder: 2 people, 10.00%
  6. Depression: 2 people, 10.00%
  7. High Blood Cholesterol: 2 people, 10.00%
  8. Adverse Drug Reaction: 2 people, 10.00%
  9. Oropharyngeal Pain: 2 people, 10.00%
  10. Scar: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Menest and Profen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Menest and Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Menest:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Menest and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Profen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on estrogens, esterified and ibuprofen (the active ingredients of Menest and Profen, respectively), and Menest and Profen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: